Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75
Cancer Cell International,
Abstract Background Bladder cancer (BCa) stands out as a prevalent and highly lethal malignancy worldwide.